Skip to main content
GINWA ENTERPRISE (GROUP) INC. logo

GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings

Ticker · 600080 ISIN · CNE000000QQ8 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2024-08-16 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 600080

About GINWA ENTERPRISE (GROUP) INC.

http://www.ginwa.com.cn/

Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.

Recent filings

Filing Released Lang Actions
金花企业（集团）股份有限公司2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2024 年半年度报告' which translates to '2024 Semi-Annual Report'. It covers the period from January 1, 2024 to June 30, 2024, indicating it is a report for a period shorter than a full fiscal year. The content includes detailed financial data such as revenue, net profit, cash flow, assets and liabilities, management discussion and analysis, business overview, risk disclosures, and other comprehensive financial and operational information. The length of the document is substantial (15,000 characters), and it contains actual financial statements and substantive analysis rather than just an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR). Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2024
2024-08-16 Chinese
金花企业（集团）股份有限公司关于公司2024年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's fundraising activities, specifically focusing on the use and management of funds raised in 2024 up to June 30. It includes detailed financial figures about the amount raised, usage, balances, and investment of idle funds. The document references regulatory approvals and compliance with Chinese securities laws. It is not a general financial report like an annual or quarterly report, nor is it an earnings release or management discussion. It is a specialized report on the use of raised capital funds, which fits the category of Capital/Financing Update (CAP). The document length is over 8,000 characters and contains substantive financial data related to fundraising and capital usage, confirming it is a report rather than a mere announcement.
2024-08-16 Chinese
金花企业（集团）股份有限公司第十届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Jinhua Enterprise (Group) Co., Ltd. It discusses the approval of the company's 2024 semi-annual report and related audit opinions, as well as a special report on the use of raised funds. The document is short (1183 characters) and serves as an announcement of the Supervisory Board's meeting decisions rather than the full semi-annual report itself. It includes voting results and compliance statements but does not contain the actual financial statements or detailed financial data. Therefore, it is not the Interim/Quarterly Report (IR) itself but an announcement related to it. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback for such announcements that do not contain full reports or detailed financial data.
2024-08-16 Chinese
金花企业（集团）股份有限公司2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '2024 年半年度报告摘要' which translates to '2024 Half-Year Report Summary'. It contains detailed financial data such as total assets, net profit, earnings per share, and shareholder information for the half-year period. The document explicitly states it is a summary of the half-year report and references the full half-year report for comprehensive details. The presence of substantive financial data and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2583 characters, which is relatively short but contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-16 Chinese
金花企业（集团）股份有限公司2024年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2024 semi-annual earnings forecast (业绩预告) for the period January 1, 2024 to June 30, 2024. It provides preliminary profit estimates and explanations for changes compared to the prior year. It explicitly states that the final accurate financial data will be disclosed in the formal 2024 semi-annual report. The document is short (1267 characters) and serves as a forecast or earnings preview rather than a full interim or quarterly report containing actual financial statements or detailed analysis. Therefore, it fits the definition of an Earnings Release (ER) as an initial announcement of periodic financial results highlights, not a full Interim/Quarterly Report (IR). H1 2024
2024-07-09 Chinese
金花企业（集团）股份有限公司关于上海证券交易所对公司2023年年度报告的信息披露监管问询函的回复公告
Regulatory Filings Classification · 95% confidence The document is a detailed reply announcement from the company regarding an inquiry from the Shanghai Stock Exchange about the company's 2023 Annual Report. It includes extensive information on the use of raised funds, project delays, market environment, sales data, and audit opinions. The document references the 2023 Annual Report and provides detailed explanations and clarifications related to it. It is not the Annual Report itself but a regulatory response to a regulatory inquiry about the Annual Report disclosures. The document is lengthy (15,000 characters) and contains substantive content, but it is primarily a regulatory disclosure and reply to a regulatory inquiry rather than the full annual report. Therefore, it fits best under Regulatory Filings (RNS) as a regulatory announcement and compliance document related to the Annual Report, not the Annual Report itself.
2024-06-26 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.